Skip to main content
Log in

Cyclosporine in the treatment of azathioprine-induced red cell aplasia following renal transplantation

  • Brief Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Azathioprine, a well-known immunosuppressive agent, is used extensively in renal transplantation. There have been several case reports of pure red cell aplasia induced by this drug following a successful kidney transplant. Previous management of azathioprine-induced red cell aplasia included reduction of azathioprine dose, or treatment with cyclophosphamide. We propose the substitution of cyclosporine for azathioprine, in this clinical setting. Not only does cyclosporine allow recovery of bone marrow function, but it maintains a level of immunosuppression which stabilizes renal function in the post-transplant patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bach JB, Dardenne M (1971) The metabolism of azathioprine in renal failure. Transplantation 12: 253–259

    PubMed  Google Scholar 

  2. Klippel JH, Decker JL (1974) Relative macrocytosis in cyclophosphamide and azathioprine therapy. JAMA 229: 180–181

    PubMed  Google Scholar 

  3. Wickramasighe SN, Dodsworth H, Rault RMJ, Hulme B (1974) Observations on the incidence and cause of macrocytosis in patients on azathioprine therapy following renal transplant. Transplantation 18: 443–446

    PubMed  Google Scholar 

  4. McGrath BP, Ibels LS, Raik E, Hargrave M, Mahony JF, Stewart JH (1975) Erythroid toxicity of azathioprine: macrocytosis and selective marrow hypoplasia. QJ Med 44: 57–63

    Google Scholar 

  5. DeClerck YA, Ettenger RB, Orkga JA, Pennisi AJ (1980) Macrocytosis and pure RBC anemia caused by azathioprine. Am J Dis Child 134: 377–379

    PubMed  Google Scholar 

  6. Old CW, Flannery EP, Grogan TM, Stone WH, SanAntonio RP (1978) Azathioprine-induced pure red cell aplasia. JAMA 240: 552–554

    PubMed  Google Scholar 

  7. Hogge DE, Wilson DR, Shumat KH, Caltram DC (1982) Reversible azathioprine-induced erythrocyte aplasia in a renal transplant recipient. Can Med Assoc J 126: 512–513

    PubMed  Google Scholar 

  8. Handschumacher RE (1990) Immunosuppressive drug. In: Goodman L, Gilman A, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon, New York, pp 1264–1276

    Google Scholar 

  9. Alexander SR, Arbus GS, Butt KMH, Conley S, Fine RN, Greifer I, Gruskin AB, Harmon WE, McEnery PT, Nevins TE, Nogueira N, Salvatierra O, Tejani A (1990) The 1989 report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 4: 542–553

    PubMed  Google Scholar 

  10. Kahan BD (1989) Cyclosporine. N Engl J Med 321: 1725–1738

    PubMed  Google Scholar 

  11. Penn I (1987) Cancers following cyclosporine therapy. Transplantation 43: 32–35

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vogt, B., Fivush, B.A. Cyclosporine in the treatment of azathioprine-induced red cell aplasia following renal transplantation. Pediatr Nephrol 6, 278–279 (1992). https://doi.org/10.1007/BF00878378

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00878378

Key words

Navigation